Pfizer CEO Albert Bourla says the company is looking for "superior" results on weight-loss drugs. Speaking with Bloomberg's Katie Greifeld at JPMorgan's annual health-care conference in San Francisco, Bourla also says he is "very satisfied" with Pfizer's current portfolio.